New York State Common Retirement Fund Has $1.75 Million Holdings in Sotera Health (NASDAQ:SHC)

New York State Common Retirement Fund trimmed its holdings in shares of Sotera Health (NASDAQ:SHC) by 20.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,777 shares of the company’s stock after selling 26,911 shares during the period. New York State Common Retirement Fund’s holdings in Sotera Health were worth $1,749,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Hawk Ridge Capital Management LP increased its stake in shares of Sotera Health by 26.9% in the third quarter. Hawk Ridge Capital Management LP now owns 2,830,614 shares of the company’s stock valued at $42,403,000 after buying an additional 600,600 shares in the last quarter. Untitled Investments LP increased its position in Sotera Health by 39.9% in the 3rd quarter. Untitled Investments LP now owns 958,595 shares of the company’s stock valued at $14,360,000 after acquiring an additional 273,520 shares in the last quarter. William Blair Investment Management LLC raised its stake in shares of Sotera Health by 7.9% in the third quarter. William Blair Investment Management LLC now owns 2,116,316 shares of the company’s stock worth $31,702,000 after acquiring an additional 154,670 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Sotera Health by 13.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,192,275 shares of the company’s stock worth $17,860,000 after purchasing an additional 143,112 shares in the last quarter. Finally, Repertoire Partners LP bought a new stake in shares of Sotera Health during the third quarter valued at approximately $2,097,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Trading Down 2.2 %

NASDAQ:SHC opened at $11.22 on Thursday. The company has a current ratio of 3.20, a quick ratio of 2.86 and a debt-to-equity ratio of 5.39. Sotera Health has a 1-year low of $10.71 and a 1-year high of $19.40. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of 59.03 and a beta of 2.08. The business’s 50-day moving average price is $12.22 and its two-hundred day moving average price is $13.98.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. The business had revenue of $310.24 million for the quarter, compared to analyst estimates of $302.17 million. Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. Sotera Health’s quarterly revenue was up 23.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.23 EPS. On average, equities analysts expect that Sotera Health will post 0.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

SHC has been the subject of several research analyst reports. Jefferies Financial Group upgraded shares of Sotera Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $15.00 to $15.50 in a research report on Monday, March 25th. Royal Bank of Canada reiterated an “outperform” rating and issued a $20.00 price target on shares of Sotera Health in a report on Monday, March 4th. Barclays lowered their price objective on Sotera Health from $19.00 to $14.00 and set an “overweight” rating for the company in a research report on Wednesday, April 10th. TheStreet upgraded shares of Sotera Health from a “d” rating to a “c-” rating in a research report on Tuesday, February 27th. Finally, KeyCorp initiated coverage on shares of Sotera Health in a research report on Tuesday, February 6th. They set a “sector weight” rating for the company. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $17.70.

Insider Buying and Selling

In other Sotera Health news, insider Michael P. Rutz sold 83,109 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.31, for a total value of $1,189,289.79. Following the completion of the transaction, the insider now directly owns 544,409 shares of the company’s stock, valued at $7,790,492.79. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider Michael P. Rutz sold 83,109 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.31, for a total value of $1,189,289.79. Following the completion of the transaction, the insider now owns 544,409 shares in the company, valued at $7,790,492.79. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Pincus & Co. Warburg sold 16,594,363 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the sale, the director now owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The disclosure for this sale can be found here. 55.12% of the stock is currently owned by company insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.